Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methyl-1-testosterone
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Methyl‑1‑testosterone (M1T; code name SC‑11195) is a synthetic and orally active anabolic–androgenic steroid (AAS) that was never marketed for medical use. It is the 17α‑methyl derivative of 1‑testosterone (dihydroboldenone). Methyl‑1‑testosterone acts as an agonist of the androgen receptor, promoting anabolic and androgenic effects in target tissues. It is considered a prohibited substance by the World Anti-Doping Agency and has been used illicitly for performance enhancement[6][8].
- Other names
- 17α-methyl-4,5α-dihydro-δ1-testosterone17α-methyl-δ1-DHT17α-methyl-5α-androst-1-en-17β-ol-3-onemethyldihydroboldenone
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on methyl-1-testosterone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methyl-1-testosterone.